{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:34:29Z","timestamp":1767652469215},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.yrtph.2008.02.001","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T16:55:02Z","timestamp":1203699302000},"page":"53-65","source":"Crossref","is-referenced-by-count":6,"title":["Nitrapyrin: A scientific advisory group review of the mode of action and carcinogenicity in B6C3F1 mice"],"prefix":"10.1016","volume":"51","author":[{"given":"B.L.","family":"Yano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Hardisty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Seely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.E.","family":"Butterworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.E.","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Swenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.E.","family":"Stebbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.B.","family":"Golllapudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.L.","family":"Eisenbrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.yrtph.2008.02.001_bib1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0278-6915(85)90265-0","article-title":"Induction of early lesions in the forestomach of rats by 3-tert-butyl-4-hydroxyanisole (BHA)","volume":"23","author":"Altmann","year":"1985","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2008.02.001_bib2","unstructured":"Bana-Lloyd, T., Szabo J.R., Rachunek, B.L., 1988a. Nitrapyrin (N-SERVE*): 2-Week Mouse Diet Probe. R&D report. Health and Environmental Sciences. The Dow Chemical Company, Lake Jackson, Texas."},{"key":"10.1016\/j.yrtph.2008.02.001_bib3","unstructured":"Barna-Lloyd, T., Szabo J.R., Rachunek, B.L., 1988b. Nitrapyrin (N-SERVE): 13-Week Mouse Dietary Toxicity Study. R&D Report. Health and Environmental Sciences. The Dow Chemical Company, Lake Jackson, Texas."},{"issue":"101","key":"10.1016\/j.yrtph.2008.02.001_bib4","first-page":"103","article-title":"Pathology of the forestomach in rats treated for 1 year with a new histamine H2-receptor antagonist, SK&F 93479 trihydrochloride","volume":"19","author":"Betton","year":"1984","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.yrtph.2008.02.001_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/rtph.1998.1273","article-title":"A comprehensive approach for integration of toxicity and cancer risk assessments","volume":"29","author":"Butterworth","year":"1999","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2008.02.001_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yrtph.2006.01.011","article-title":"A classification framework and practical guidance for establishing a mode of action for chemical carcinogens","volume":"45","author":"Butterworth","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2008.02.001_bib7","unstructured":"Carreon, R.E., 1986. 2-Chloro-6-(Trichloromethyl)pyridine: Primary Eye Irritation Study in New Zealand White Rabbits. R&D Report. Health and Environmental Sciences. The Dow Chemical Company, Midland, Michigan."},{"key":"10.1016\/j.yrtph.2008.02.001_bib8","unstructured":"Cosse, P.F., Stebbins, K.E., Stewart, H.S., 1992. Nitrapyrin: Probe and 21-Day Repeated Dose Dermal Toxicity Study in New Zealand White Rabbits. R&D Report. Health and Environmental Sciences. The Dow Chemical Company, Midland, Michigan."},{"key":"10.1016\/j.yrtph.2008.02.001_bib9","series-title":"A subchronic (3-month) oral toxicity study of nitrapyrin in the mouse via dietary administration","author":"Daly","year":"1995"},{"key":"10.1016\/j.yrtph.2008.02.001_bib10","series-title":"International Classification of Rodent Tumors: The mouse","article-title":"Liver, gallbladder, and exocrine pancreas","author":"Deschl","year":"2001"},{"key":"10.1016\/j.yrtph.2008.02.001_bib11","unstructured":"EEC, 2000. Directive 2000\/32\/EC, of 19 May 2000 Adapting to Technical Progress for the 26th Time. Council Directive 67\/548\/EEC Publication No. L136."},{"key":"10.1016\/j.yrtph.2008.02.001_bib12","first-page":"295","article-title":"Role of mitotic activity in target tissues in N-nitrosodiethylamine carcinogenesis","volume":"51","author":"Ehivest","year":"1983","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.yrtph.2008.02.001_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0272-0590(91)90175-4","article-title":"Mouse liver carcinogenesis: mechanisms and relevance","volume":"17","author":"Goodman","year":"1991","journal-title":"Fundam Appl. Toxicol."},{"issue":"3","key":"10.1016\/j.yrtph.2008.02.001_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/019262339802600318","article-title":"Spontaneous neoplasms incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program Update","volume":"26","author":"Haseman","year":"1998","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2008.02.001_bib15","series-title":"Pathology of the mouse. Liver and gallbladder","author":"Harada","year":"1999"},{"key":"10.1016\/j.yrtph.2008.02.001_bib16","unstructured":"IARC (International Agency for Research on Cancer), 2003. World Health Organization predictive value of rodent forestomach and gastric neuroendocrine tumours in evaluating carcinogenic risks to humans. In: Views and Expert Opinions of an IARC Working Group, Lyon, 29 November\u20131 December, 1999, IARC Technical Publication No. 39,2003."},{"key":"10.1016\/j.yrtph.2008.02.001_bib17","first-page":"343","article-title":"Carcinogenicity of butylated hydroxyanisole in F344 rats","volume":"70","author":"Ito","year":"1983","journal-title":"JNCI"},{"key":"10.1016\/j.yrtph.2008.02.001_bib18","unstructured":"Kennelly, J.C., 1985. Study to determine the ability of nitrapyrin to induce mutation in four histidine-requiring of Salmonella typhimurium. Study No. DCE 3\/S\/SR\/AF2. Unpublished study prepared by Microtest Research Limited, 39pp."},{"key":"10.1016\/j.yrtph.2008.02.001_bib19","unstructured":"Kirkland, D.J., 1985. Nitrapyrin: micronucleus test in mice. Study No. DCE 3\/MNT\/AR\/KF11. Unpublished study prepared by Microtest Research Limited, 26pp."},{"issue":"11","key":"10.1016\/j.yrtph.2008.02.001_bib20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0278-6915(86)90292-9","article-title":"Forestomach carcinogens: possible mechanisms of action","volume":"24","author":"Kroes","year":"1986","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2008.02.001_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/faat.1994.1012","article-title":"Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: comparison of administration by gavage in corn oil vs. ad libitum in drinking water","volume":"22","author":"Larson","year":"1994","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2008.02.001_bib22","unstructured":"Linscombe, V.A., Gollapudi, B.B., 1986. Evaluation of Nitrapyrin in the Chinese Hamster Ovary Cell\/Hypoxanthine-Guanine-Phosphoribosyl Transferase (CHO\/HGPRT) Forward Mutation Assay. R&D Report. Health and Environmental Sciences. The Dow Chemical Company, Lake Jackson, Texas."},{"key":"10.1016\/j.yrtph.2008.02.001_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0165-1218(88)90029-8","article-title":"The Japanese mutagenicity guidelines for pesticide registration","volume":"205","author":"Shirasu","year":"1988","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2008.02.001_bib24","unstructured":"Mecchi, M.S., 2007. Salmonella\u2013Escherichia coli\/Mammalian-Microsome Reverse Mutation Assay Preincubation Method with a Confirmatory Assay with Nitrapyrin TGAI Covance Laboratories, Inc., Vienna, Virginia."},{"key":"10.1016\/j.yrtph.2008.02.001_bib25","unstructured":"Mendrala, A.L., Schumann, A.M., 1982. N-SERVE TG (Nitrapyrin: 2-Chloro-6-(Trichloromethyl)pyridine): Evaluation of N-SERVE TG in the Rat Hepatocyte Unscheduled DNA Synthesis Assay. R&D Report. Health and Environmental Sciences. The Dow Chemical Company, Midland, Michigan."},{"key":"10.1016\/j.yrtph.2008.02.001_bib26","doi-asserted-by":"crossref","unstructured":"Maronpot, R.R., Haseman, J.K., Boorman, G.A., Eustis, S.E., Rao, G.N., Huff, J.E., 1987. Liver Lesions in B6C3F1 Mice, the National Toxicology Program, Experience and Position.","DOI":"10.1007\/978-3-642-71617-1_2"},{"key":"10.1016\/j.yrtph.2008.02.001_bib27","series-title":"Handbook of Toxicologic Pathology","article-title":"Chemical carcinogenesis","author":"Maronpot","year":"1991"},{"issue":"1","key":"10.1016\/j.yrtph.2008.02.001_bib28","first-page":"22","article-title":"A review of the toxicological, residual, and environmental effects of nitrapyrin and its metabolite 6-chloropicolinic acid","volume":"32","author":"Mullison","year":"1976","journal-title":"Down To Earth"},{"key":"10.1016\/j.yrtph.2008.02.001_bib29","unstructured":"Norris, M., 1971. Acute Toxicologic Properties of Dowco 163. R&D Report. Health and Environmental Sciences. The Dow Chemical Company, Midland, Michigan."},{"key":"10.1016\/j.yrtph.2008.02.001_bib30","unstructured":"OECD, 1997. Guidelines for Testing Chemicals, Guideline 471, Bacterial Reverse Mutation Test, updated and adopted July 21, 1997."},{"key":"10.1016\/j.yrtph.2008.02.001_bib31","unstructured":"Quast, J.F., Cosse, P.F., Corley, R.A., 1990. Nitrapyrin (N-SERVE*): Two-Year Dietary Oncogenicity Study in B6C3F1 Mice. R&D Report. Health and Environmental Sciences. The Dow Chemical Company, Midland, Michigan."},{"issue":"4","key":"10.1016\/j.yrtph.2008.02.001_bib32","first-page":"519","article-title":"Tracer study of residues from 2-chloro-6(trichloromethyl)pyridine in plants","volume":"13","author":"Redemann","year":"1965","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.yrtph.2008.02.001_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1293\/tox.7.95","article-title":"Primary histiocytic sarcoma of the epididymis in B6C3F1 mouse","volume":"7","author":"Shiga","year":"1994","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2008.02.001_bib34","unstructured":"Stebbins, K.E., Cosse, P.F., 1997. Nitrapyrin (N-serve* nitrogen stabilizer): Two-Year Dietary Oncogenicity Study in B6C3F1 Mice. R&D Report. Health and Environmental Sciences. The Dow Chemical Company, Midland, Michigan."},{"key":"10.1016\/j.yrtph.2008.02.001_bib35","unstructured":"Szabo, J.R., Landenberger, B.D., Rachunek, B.L., 1989. Nitrapyrin (N-SERVE*): Two-Year Chronic Toxicity and Oncogenicity Study in Fischer 344 Rats. R&D Report. Health and Environmental Sciences. The Dow Chemical Company, Lake Jackson, Texas."},{"key":"10.1016\/j.yrtph.2008.02.001_bib36","first-page":"19","article-title":"N-serve a status report","volume":"22","author":"Turner","year":"1966","journal-title":"Down to Earth"},{"key":"10.1016\/j.yrtph.2008.02.001_bib37","unstructured":"US EPA CPRC, 1992. Carcinogenicity Peer Review of Nitrapyrin, September, 14, 1992. HED Doc. No. 009760."},{"key":"10.1016\/j.yrtph.2008.02.001_bib38","unstructured":"US EPA, 1998. Health Effects Test Guidelines, August, 1998. OPPTS 870.5100, Bacterial Reverse Mutation Test."},{"key":"10.1016\/j.yrtph.2008.02.001_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3835(97)00229-2","article-title":"Chemicals with carcinogenic activity in the rodent liver; mechanistic evaluation of human risk","volume":"117","author":"Williams","year":"1997","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.yrtph.2008.02.001_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/01926230252824699","article-title":"Alteration of liver cell function and proliferation: differentiation between adaptation and toxicity","volume":"30","author":"Williams","year":"2002","journal-title":"Toxicol. Pathol."},{"issue":"1-2","key":"10.1016\/j.yrtph.2008.02.001_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0163-7258(96)00066-6","article-title":"Butylated hydroxyanisole mechanistic data and risk assessment: conditional species-specific cytotoxicity, enhanced cell proliferation, and tumor formation","volume":"71","author":"Whysner","year":"1996","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.yrtph.2008.02.001_bib42","unstructured":"Yano, B.L., McFadden, L.G., 1996. Nitrapyrin (N-SERVE* Nitrogen Stabilizer): Quantitation of Hepatocyte Proliferation and Apoptosis in a 2-Week Dietary Toxicity Study in B6C3F1 Mice\u2014A Retrospective Study. R&D Report. Health and Environmental Sciences. The Dow Chemical Company, Midland, Michigan."},{"issue":"12","key":"10.1016\/j.yrtph.2008.02.001_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/em.2850110602","article-title":"Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals","volume":"11","author":"Zieger","year":"1988","journal-title":"Environ. Mol. Mutagen."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230008000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230008000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T07:09:28Z","timestamp":1557299368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230008000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0273230008000354"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2008.02.001","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}